Can the total consumption of a medicinal drug be used as an indicator of excessive use? The case of carisoprodol

References

• Bailey DN, Briggs JR. Carisoprodol: An unrecognized drug of abuse. American Journal of Clinical Pathology 2002; 117: 396–400
   PubMed Web of Science ®Google Scholar
• Barat I, Andreasen F, Damsgaard EM. The consumption of drugs by 75-year-old individuals living in their own homes. European Journal of Clinical Pharmacology 2000; 56: 501–509
   PubMed Web of Science ®Google Scholar
• Berger F, Kletzkin M, Ludwig B, Margolin S. The history, chemistry, and pharmacology of carisoprodol. Annals of the New York Academy of Sciences 1960; 86: 90–107
   PubMed Web of Science ®Google Scholar
• Boothby L, Doering P, Hatton R. Carisoprodol: A marginally effective skeletal muscle relaxant with serious abuse potential. Hospital Pharmacy 2003; 38: 337–345
   Google Scholar
• Bramness JG, Furu K, Engeland A, Skurtveit S. Carisoprodol use and abuse in Norway. A pharmacoepidemiological study. British Journal of Clinical Pharmacology 2007; 64: 210–218
   PubMed Web of Science ®Google Scholar
• Bramness JG, Skurtveit S, Grung M, Mørland J. Centrally acting muscle relaxants: Abuse potential and traffic hazards. Tidsskrift for Den Norske Laegeforening 2000; 120: 1966–1969
   PubMedGoogle Scholar
• Bramness JG, Skurtveit S, Mørland J. Detection of zopiclone in drivers. A sign of misuse and abuse. Tidsskrift for Den Norske Laegeforening 1999; 119: 2820–2821
   PubMedGoogle Scholar
• Buajordet, I. & Madsen, S. (2007). [Somadril recalled in Norway]. Tidsskrift for Den Norske Laegeforening, 127, 1397.
   Google Scholar
• Dahl E, Grenthe B, Lindqvist B. Comparison of changes in pain threshold following oral administration of carisoprodol, acetylsalicyclic acid, and placebo. Swedish Dental Journal 1981; 5: 77–80
   PubMed Web of Science ®Google Scholar
• Fraser, H., Essig, C. & Wolbach, A. (1961) Evaluation of carisoprodol and phenyramidol for addictiveness. National Institute of Mental Health, Addiction Research Centre, from http://www.unodc.org/unodc/en/bulletin/bulletin_1961-01-01_4_page002.html. Retrieved on October 5, 2009.
   Google Scholar
• Furu K. Drug utilisation in a public health perspective: Establishing a national prescription register in Norway. Norway Journal of Epidemiology 2001; 11: 55–60
   Google Scholar
• Furu K, Strøm H, Rønning M, Skurtveit S, Engeland A, Tverdal A. The Norwegian Prescription Database (NorPD): New register for pharmacoepidemiological research coveringa whole nation. Pharmacoepidemiology and Drug Safety 2005; 14: S48
   Google Scholar
• Gadeholt G. Somadril Comp. “Dumex” Marketing authorisation withdrawn. News from the Norwegian Medicinal Authorities 1995; page 4
   Google Scholar
• Gallardo F, Molgo J, Miyazaki C, Rossi E. Carisoprodol in the treatment of myofascial pain-dysfunction syndrome. Journal of Oral Surgery 1975; 33: 655–658
   Google Scholar
• Glintborg B, Olsen L, Poulsen H, Linnet K, Dalhoff K. Reliability of self-reported use of amphetamine, barbiturates, benzodiazepines, cannabinoids, cocaine, methadone, and opiates among acutely hospitalized elderly medical patients. Clinical Toxicology (Phila) 2008; 46: 239–242
   PubMed Web of Science ®Google Scholar
• Hallas J. Drug utlization statistics for individual-level pharmacy dispensing data. Pharmacoepidemiology and Drug Safety 2005; 14: 455–463
   PubMed Web of Science ®Google Scholar
• Hallas J, Støvring H. Templates for analysis of individual-level prescription data. Basic & Clinical Pharmacology & Toxicology 2006; 98: 260–265
   PubMed Web of Science ®Google Scholar
• Hansen M, Rossow I. Adolescent gambling and problem gambling: Does the total consumption model apply?. Journal of Gambling Studies 2008; 24: 135–149
   PubMed Web of Science ®Google Scholar
• Høiseth G, Bramness J, Christophersen A, Mørland J. Carisoprodol Intoxications: A retrospective study of a forensic autopsy material 1992–2003. International Journal of Legal Medicine 2006; 121: 403–409
   PubMed Web of Science ®Google Scholar
• Høiseth G, Sørlid H, Bramness J. Carisoprodol Intoxications: Contacts to the Norwegian Poinsions information 1999–2004. Clinical Toxicology 2007; 46: 307–309
   Google Scholar
• Isacson D, Bingefors K, Wennberg M, Dahlström M. Factors associated with high-quantity prescriptions of benzodiazepines in Sweden. Social Science & Medicine 1993; 36: 343–351
   PubMed Web of Science ®Google Scholar
• Kampmann J. Sovemedicine og nervemedicine–storforbrugere. Lægemiddelstyrelsen, København 1997
   Google Scholar
• Ledermann S. Alcool, alcoolisme, alcoolisation: Mortalité, morbidité, accidents du travail. Presses Universitaires de France (Institut National d'Études Démographiques: Travaux et Documents), Paris 1964
   Google Scholar
• Lemmens PHHM. Measurement and distribution of alcohol consumption. University of Maastricht, Maastricht 1991
   Google Scholar
• Logan BK, Case GA, Gordon AM. Carisoprodol, meprobamate, and driving impairment. Journal of Forensic Sciences 2000; 45: 619–623
   PubMed Web of Science ®Google Scholar
• Lund I. The population mean and the proportion of frequent gamblers: Is the theory of total consumption valid for gambling?. Journal of Gambling Studies 2008; 24: 247–256
   PubMed Web of Science ®Google Scholar
• Makela P, Paljarvi T, Poikolainen K. Heavy and nonheavy drinking occasions, all-cause and cardiovascular mortality and hospitalizations: A follow-up study in a population with a low consumption level. Journal of Studies on Alcohol 2005; 66: 722–728
   PubMed Web of Science ®Google Scholar
• Miller AR. A comparative study of Parafon Forte tablets and Soma compound in the treatment of painful skeletal muscle conditions. Current Therapeutic Research-Clinical and Experimental 1976; 19: 444–450
   PubMed Web of Science ®Google Scholar
• Paulozzi LJ, Ryan GW. Opioid analgesics and rates of fatal drug poisoning in the United States. American Journal of Preventive Medicine 2006; 31: 506–511
   PubMed Web of Science ®Google Scholar
• Reeves RR, Carter OS, Pinkofsky HB, Struve FA, Bennett DM. Carisoprodol (soma): Abuse potential and physician unawareness. Journal of Addictive Diseases 1999; 18: 51–56
   PubMed Web of Science ®Google Scholar
• Reeves RR, Parker JD. Somatic dysfunction during carisoprodol cessation: Evidence for a carisoprodol withdrawal syndrome. Journal of American Osteopathic Association 2003; 103: 75–80
   PubMedGoogle Scholar
• Rose G. Sick individuals and sick populations. International Journal of Epidemiology 1985; 14: 32–38
   PubMed Web of Science ®Google Scholar
• Rose G, Day S. The population mean predicts the number of deviant individuals. British Medical Journal 1990; 301: 1031–1034
   PubMed Web of Science ®Google Scholar
• Rønning M, Sakshaug S, Berg C, Litleskare I, Strøm H, Granum T. Drug consumption in Norway 2001–2005. Folkehelseinstituttet, Oslo 2006
   Google Scholar
• Skog OJ. Total alcohol consumption and rates of excessive use: A rejoinder to Duffy and Cohen. British Journal of Addiction 1980; 75: 133–145
   PubMedGoogle Scholar
• Skog OJ. The collectivity of drinking cultures: A theory of the distribution of alcohol consumption. British Journal Addiction 1985; 80: 83–99
   PubMedGoogle Scholar
• Skog OJ, Rossow I. Flux and stability: Individual fluctuations, regression towards the mean and collective changes in alcohol consumption. Addiction 2006; 101: 959–970
   PubMed Web of Science ®Google Scholar
• Skurtveit, S., Christophersen, A. S. & Mørland, J. (1995) Driving under the influence of benzodiazepines. Sale differences in the counties are reflected among drivers suspected of driving under the influence of a drug. Tidsskrift for Den Norske Laegeforening, 115, 200–203.
   Google Scholar
• Soyka J, Maestripieri L. Soma compound (carisoprodol plus phenacetin and caffeine) in the treatment of acute, painful musculoskeletal conditions. Current Therapeutic Research 1979; 26: 165–180
   Web of Science ®Google Scholar
• Substance Abuse and Mental Health Service Administration Office of Applied Studies (2003) Emergency Department Trends From the Drug Abuse Warning Network, Final estimates 1995–2002. Rockville, MD, DAWN Series D-24
   Google Scholar
• Van Tulder M, Waddell G. Akuta ländryggsbesvär–konservativ behandling. Ont i ryggen, ont i nacken. En evidensbaserad kunskapssammanställning. SBU, Stockholm 2000
   Google Scholar
• Varley, H., Jordan, J. & Bascom, P. (2000) Quantities of carisoprodol (Soma(R)) to be restricted. DUR Newsletter 2000. From http://pharmacy.oregonstate.edu/drug_policy/news/2_4/2_4.htm. Retrieved on October 5, 2009.
   Google Scholar
• Værøy H, Abrahamsen A, Førre Ø, Kristiansen P, Kåss E. Treatment of patients with fibromyalgia: A double blind clinical trial with Somadril Comp (carisprodol, paracetamol) versus placebo. Scandinavian Journal of Rheumatology 1988; 72: 38S
   Google Scholar
• Waddell G, McIntosh A, Hutchinson A, Feder G, Lewis M. Low back pain evidence review. Royal College of General Practitioners, London 1999
   Google Scholar
• WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. WHO, Oslo 2005
   Google Scholar